Platinum Investment Management Ltd. acquired a new position in Aura Biosciences, Inc. (NASDAQ:AURA – Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 180,145 shares of the company’s stock, valued at approximately $1,596,000. A number of other institutional investors have also added […]
Decheng Capital LLC Acquires New Holdings in Aura Biosciences, Inc (NASDAQ:AURA) wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
Aura Biosciences (NASDAQ:AURA – Get Free Report) and Caribou Biosciences (NASDAQ:CRBU – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, risk, dividends, institutional ownership and profitability. Institutional and Insider Ownership 96.8% of Aura […]
Levin Capital Strategies L.P. grew its position in shares of Aura Biosciences, Inc. (NASDAQ:AURA – Free Report) by 15.9% during the third quarter, according to its most recent filing with the SEC. The firm owned 81,095 shares of the company’s stock after acquiring an additional 11,095 shares during the period. Levin Capital Strategies L.P. owned […]
Aura Biosciences (NASDAQ:AURA – Free Report) had its price target reduced by BTIG Research from $38.00 to $21.00 in a research report released on Friday, Benzinga reports. BTIG Research currently has a buy rating on the stock. Separately, JMP Securities lowered their target price on shares of Aura Biosciences from $21.00 to $19.00 and set […]